Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 12.69
(-0.47%)
CNY 12.69
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.4 Billion | 20.28 Billion | 13.08 Billion | 10.64 Billion | 8.45 Billion | 6.96 Billion |
| Cost of Revenue | 9.25 Billion | 12.74 Billion | 8.07 Billion | 6.57 Billion | 5.73 Billion | 4.59 Billion |
| Gross Profit | 4.15 Billion | 7.53 Billion | 5 Billion | 4.07 Billion | 2.71 Billion | 2.37 Billion |
| Operating Expenses | 3.35 Billion | 3.46 Billion | 2.72 Billion | 2.05 Billion | 1.63 Billion | 1.44 Billion |
| Selling, General and Administrative Expenses | 2.67 Billion | 1.86 Billion | 1.43 Billion | 1.17 Billion | 956.82 Million | 836.03 Million |
| Research and Development Expenses | 432.64 Million | 638.47 Million | 424.74 Million | 319.1 Million | 211.91 Million | 166.26 Million |
| Other Expenses | 201.22 Million | 961.48 Million | 861.91 Million | 564.85 Million | 464.43 Million | 12.67 Million |
| Cost and Expenses | 12.56 Billion | 16.21 Billion | 10.8 Billion | 8.63 Billion | 7.36 Billion | 6.04 Billion |
| Operating Income | 998.13 Million | 3.81 Billion | 1.83 Billion | 2.07 Billion | 1.19 Billion | 721.39 Million |
| Interest Expense | 250.6 Million | 274.72 Million | 230.19 Million | 206.81 Million | 219.89 Million | 170.32 Million |
| Income Tax Expense | 216.73 Million | 681.09 Million | 307.39 Million | 247.46 Million | 195.6 Million | 145.61 Million |
| Earnings before Tax | 805.04 Million | 2.54 Billion | 1.79 Billion | 1.31 Billion | 771.17 Million | 734.07 Million |
| Net Income | 307.46 Million | 1.43 Billion | 1.16 Billion | 802.93 Million | 575.56 Million | 388.6 Million |
| Earnings Per Share Basic | 0.50 | 2.30 | 1.87 | 1.29 | 0.93 | 0.71 |
| Earnings Per Share Diluted | 0.49 | 2.30 | 1.87 | 1.29 | 0.93 | 0.71 |
| Weighted Average Shares Outstanding | 619.44 Million | 622.96 Million | 620.45 Million | 620.45 Million | 620.45 Million | 547.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 625.17 Million | 624.02 Million | 620.45 Million | 620.45 Million | 620.45 Million | 547.33 Million |
| Gross Margin | 0.31 | 0.37 | 0.38 | 0.38 | 0.32 | 0.34 |
| EBIT Margin | 0.14 | 0.23 | 0.21 | 0.22 | 0.17 | 0.17 |
| Profit Margin | 0.02 | 0.07 | 0.09 | 0.08 | 0.07 | 0.06 |
| EBITDA | 1.86 Billion | 3.69 Billion | 2.51 Billion | 1.88 Billion | 1.23 Billion | 1.08 Billion |
| Earnings Before Tax Margin | 0.07 | 0.19 | 0.14 | 0.20 | 0.14 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.03 Billion | 3.23 Billion | 2.96 Billion | 13.36 Billion | 3.1 Billion | 3.45 Billion |
| Cost of Revenue | 2.16 Billion | 2.3 Billion | 2.21 Billion | 9.3 Billion | 2.32 Billion | 2.34 Billion |
| Gross Profit | 875.06 Million | 933.33 Million | 749.01 Million | 4.05 Billion | 781.99 Million | 1.1 Billion |
| Operating Expenses | 541.91 Million | 746.46 Million | 596.33 Million | 3.05 Billion | 926.12 Million | 620.64 Million |
| Selling, General and Administrative Expenses | 1.11 Billion | 669.94 Million | 522.54 Million | - | 806.99 Million | 853.49 Million |
| Research and Development Expenses | 70.52 Million | 75.34 Million | 72.33 Million | - | 103.15 Million | 102.67 Million |
| Other Expenses | -644.07 Million | -1.17 Million | -1.45 Million | -62.99 Thousand | -15.96 Million | -2.1 Million |
| Cost and Expenses | 2.7 Billion | 3.04 Billion | 2.81 Billion | 12.36 Billion | 3.24 Billion | 2.96 Billion |
| Operating Income | 188 Million | 186.87 Million | 152.67 Million | 998.13 Million | -144.13 Million | 252.65 Million |
| Interest Expense | 58.92 Million | 41.55 Million | 54.89 Million | 250.6 Million | 52.66 Million | 63.27 Million |
| Income Tax Expense | 47.68 Million | 48.83 Million | 24.97 Million | 216.73 Million | -13.27 Million | 70.41 Million |
| Earnings before Tax | 177.73 Million | 137.42 Million | 105.5 Million | 805.04 Million | -216.51 Million | 250.54 Million |
| Net Income | 59.11 Million | 48.57 Million | 23.17 Million | 307.46 Million | -223.41 Million | 77.58 Million |
| Earnings Per Share Basic | 0.10 | 0.08 | 0.04 | - | -0.36 | 0.12 |
| Earnings Per Share Diluted | 0.10 | 0.08 | 0.04 | - | -0.36 | 0.12 |
| Weighted Average Shares Outstanding | 612.53 Million | 613.49 Million | 614.41 Million | 619.44 Million | 619.44 Million | 624.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 612.53 Million | 626.07 Million | 614.41 Million | 619.44 Million | 619.44 Million | 626.19 Million |
| Gross Margin | 0.29 | 0.29 | 0.25 | 0.30 | 0.25 | 0.32 |
| EBIT Margin | 0.08 | 0.11 | 0.09 | - | 0.03 | 0.11 |
| Profit Margin | 0.02 | 0.02 | 0.01 | 0.02 | -0.07 | 0.02 |
| EBITDA | 236.65 Million | 364.09 Million | 257.8 Million | - | 85.76 Million | 392.97 Million |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.05 | 0.07 | -0.05 | 0.07 |
REY
8TRA
300339
KILITCH
BUVA
POR